Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Gut microbiota & Non-Alcoholic Steatohepatitis (NASH)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

In dysbiosis, pathobionts and microbial metabolites can cause Non-Alcoholic Steatohepatitis (NASH / MASH) by affecting barrier integrity, hepatic lipid metabolism and promoting inflammation and fibrosis
Kolodziejczyk et al. 2019a EMBO Mol Med 11: e9302

Non-Alcoholic Steatohepatitis (NASH) goes along with a low concentration of [Secondary bile salts / Secondary bile a…

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
Gillard et al. 2021 JHEP Reports 4(1): 100387
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.
Zhu et al. 2013 Hepatology 57: 601-609
Microbiota, NASH, HCC and the potential role of probiotics
Brandi et al. 2017 Carcinogenesis 38: 231-240
Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales
Carter et al. 2021 PLoS ONE 16(1): e0244763
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui 2019 Diseases 7: 58
Review
The Role of the Microbiome in NAFLD and NASH
Kolodziejczyk et al. 2019a EMBO Mol Med 11: e9302
Review
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
Boursier et al. 2016 Hepatology 63: 764-775

7/2/2026